foxo4-dri senolytic or senomorphic

foxo4-dri senolytic or senomorphic Class II senolytics inhibit survival pathways elicited by senescent Targeting cellular senescence with senotherapeutics:

Name: foxo4-dri senolytic or senomorphic Class II senolytics inhibit survival pathways elicited by senescent Targeting cellular senescence with senotherapeutics:
Brand: metron-ms.com
SKU: 28104614909
Price: 21.19 USD
Availability: InStock
Rating: 4.6687 (10 reviews)

Targeting cellular senescence with senotherapeutics: senolytics and senomorphics Zhang 2023 The FEBS Journal Wiley Online Library Cleara Biotech senolytic candidate FOXO4 DRI Targeting Cellular Senescence in Aging and Age Related Diseases: Challenges, Considerations, and the Emerging Role of Senolytic and Senomorphic Therapies Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications

SKU: 28104614909 · From metron-ms.com

4.7

USD21.19 USD54.19

Pay in 4 interest-free payments of $5.30 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 4 - Aug 9

Description

The peptide also demonstrates cytoprotective properties by modulating the expression of genes involved in oxidative stress response and inflammatory cascades

Warten Sie nach der Injektion etwa 10 Sekunden , bevor Sie die Nadel herausziehen

NAD+ Therapy Although physicians often include both therapies in wellness and longevity programs, they support the body in different ways

Journal Member We associated with 200+reputed SCI and SCOPUS indexed journals (SJR ranking) for getting research work to be published in standard journals (Your first-choice journal)